Cellexus Biosystems reports the Granting of Fundamental Technology UK Patent
The Board of Cellexus Biosystems plc announced that the Company has been issued with the British patent GB2433216 covering the core technology for the CellMaker family of disposable bioreactor and fermentor products.
Commenting on this granting by the UK Patent Office, the inventor of the CellMaker technology, Dr Kevin Auton, commented: "The grant of this first patent for the Cellexus technology is an important milestone for Cellexus Biosystems as it provides us with the protection we require to exploit our position in cell culture and fermentation and validates the novelty of our single-use bioreactor and fermentors. We now routinely demonstrate that the CellMaker technology is as effective as a traditional stirred bioreactor, even for fermentation, which requires high rates of oxygen transfer. High mass transfer of oxygen is achieved without moving parts and is a result of the unique bioreactor geometry. This patent will be filed in all major markets and has already been filed in the US".
Other news from the department research and development
